Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07GNO
|
|||
| Former ID |
DNCL002072
|
|||
| Drug Name |
KRN-330
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Colorectal cancer [ICD-11: 2B91.Z] | Phase 1/2 | [1] | |
| Company |
Kyowa Hakko Kirin Pharma
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cell surface A33 antigen (GPA33) | Target Info | . | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Phase 1/2 study of KRN330, a fully human anti-A33 monoclonal antibody, plus irinotecan as second-line treatment for patients with metastatic colorectal cancer. Invest New Drugs. 2014 Aug;32(4):682-90. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.